#unit 4402 reporting

[brisquad-unit-4402]

when that wilson enemies to lovers fic is posted, TRUST that i’ll get out my snacks and drinks while lounging on the couch to read it like i’m watching a movie in theaters 🤞

omg hi celeste. here take this except (body horror + insect warning)

[Wilson] had met you by circumstance. High-value jobs tend to target the same people, since their influence was seconded only by their value. One moment he had busted through the vents only to find that his target already died, a space on their neck turning pale blue from a poison bite. Then the next he felt the wind get knocked out of him as he was slammed against a wall with his feet in the air. The person that pinned him had a cloth face mask on their chin, and above it, insectoid mandibles writhed at the jaw, frothing with the cause of his target's death.

Wilson screamed, of course. Who wouldn't? Especially when he realized that only one arm held him in place even though he was paralyzed. It wasn't even an arm; hundreds of segmented legs held him down as a gigantic centipede body took place of the limb.

"I was instructed to kill a politician, not a bodyguard." The clicking mandibles melted into flesh, but you raised your mask before he could make out any of your features. The only thing he could see was your hair and eyes, thankfully human, though they shone with facets of compound eyes and the iridescence of an insect magnified. "I must offer a discount to my client for not following their criteria, but selling your organs will make up for the loss."

"Nope!" Wilson blustered, suddenly feeling very protective over his liver. "I-I-I also was supposed to kill them, but lucky me, it's already been done! Guess I'll…" he trailed off as the centipede legs inched up his neck and onto his face.

"...I'll go home?" He pleaded. He blinked owlishly, mustering up the best puppy eyes he could, and silently thanked his lucky stars his goggles were on properly. If those legs got any closer to his eyes he'd really start freaking out. "Please?"

You stared back at him unamused. Not that he could tell, considering the mask obscuring your face. "You got a name? One or two kidneys?"

"Yu Q. Wilson! I'm a hitman, and I think my client wanted them gone because they're political rivals, and it's really rare to work in this industry without selling a kidney along the way so please don't take mine, I like having them both—uff!"

You flicked your centipede arm away. Wilson crumpled to the ground, having lost his breath a second time. He held a hand to his chest to still his beating heart, especially since he was only a few feet away from the politician and the poison dripping from their bite.

"Our employer is an idiot," you say curtly. "They pay two separate assassins an upfront fee, and one of them doesn't even value their privacy."

"Hey, I do too value their privacy."

"Then you made a mistake telling me a single detail about them. Get up."

Wilson remembered how to walk at your command. He stood up, resting a hand on the wall, still affected by the shock of a centipede-person nearly biting his head off. "Wait, none of the alarms have gone off. There's supposed to be security checking this area soon, especially since I screamed."

"Then leave."

He opened his mouth to respond but failed to speak as you fell straight backward. The hitman reached out to grab you, but you've disappeared right before his very eyes.

Wilson stood there, the room turning acrid with the dead body and its poison, and no trace of the insectoid assassin. On cue, he bristled. Footsteps approached the door.

He scrambled back up the vents, shutting the grate behind him with a slam, not even noticing the spider that perched on the sheath of his sword as he rose, waiting for its opportunity to breach the surface in the dead of night as a killer is wont to do…

[brisquad-unit-4402]

pleas.

inspired by boop day, reblog this post if its ok for people to send you random asks and interact on your posts with no judgement. i want to talk to people.

[kanekoii]

hello this is brisquad-unit-4402 reporting. let’s do a matchup trade!

i may be an introvert but i love being the noisy, silly, adventurous friend when i’m with people i trust. i love to laugh and make others laugh too, even if i end up being the butt end of the joke. i just like rolling at my own pace! and if someone gets in the way of that or the people i care about, i’m a believer in “fuck around and find out”. i end up being the one to ask for no pickles on my friend’s burger

i’m a writer first and foremost but i love fashion and i love music! i have an art journal and i like to stream horror games to my friends that are too scared to play it themselves. my comfort movie is midsommar, my love language is gift giving, and i’m known to eat dangerous food but i’ve never had food poisoning. i end up taking the lead most of the time in a relationship, even though i’m prone to being a tsundere and it’s nice to be pampered every once in a while

after being hit with the Morning Beam, it is time for me to fulfill the prophecy!

!! this isn't really intended for anyone other than 4402 !!

I've matched you with...

I think his personality just meshes well with yours! I could totally see you and him going on adventures together, laughing and making jokes the whole time. He knows you love Splatoon, so he would gladly just watch you play it and be amazed by your skill. i totally see him taking you to get some ramen and boba together and just cute casual dates like that and watching movies!! it would be the cutest thing ever, just chilling with you makes him happy. claude also ADORES the way you dress, it's just so awesome and cool looking! all in all, he's the first choice when it comes to a good partner and friend! he doesn't mind you taking the lead in the relationship, but he would love to pamper you whenever you want it! it makes him happy <3

RUNNER UP (i can't find a good img :cryign:)

i would match him with you for the same reasons as the other match! he's just a silly fella and would be so silly with you!

[albus077]

Carbon Fiber Reinforced Plastic Market

Research Nester published a report titled “Carbon Fiber Reinforced Plastic Market: Global Demand Analysis & Opportunity Outlook 2033” which delivers detailed overview of the global carbon fiber reinforced plasticin terms of market segmentation by raw material, type, application, and by region.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.

The global carbon fiber reinforced plastic market is anticipated to grow with a CAGR of ~8% during the forecast period, i.e. 2023-2033. The market is segmented by application into aerospace & defense, wind turbine, automotive, sports equipment, building & construction, and others. Out of these, the automotive segment is attributed to garner the highest market share by 2033, owing to the high sales of the vehicles across the globe. As per Organization of Motor Vehicle Manufacturers, the sales of vehicles rose from 78, 774,320 units in 2020 to 82, 684, 788 in 2021.

The global carbon fiber reinforced plastic market is estimated to garner a notable revenue by 2033. Carbon fiber reinforced plastics are being highly utilized owing to their beneficial characteristics such as high load bearing capacity, light weight, and high fatigue strength. Safety is considered the primary factor in the automotive sector, and thus the advantages of carbon fiber reinforced plastic make it the most preferred option. Also, carbon fiber reinforced plastics are good at absorbing high impact energy as compared to steel, making them ideal for producing luxury cars. Also, carbon fiber reinforced plastics are 30 times lighter than aluminum, making it viable to enhance the performance of vehicles.

Geographically, the global carbon fiber reinforced plastic market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Out of these, the market in Asia Pacific region is estimate to garner the largest market share by the end of 2033, on the back of increased sales and production of vehicles. International Organization of Motor Vehicles, stated that the total production of vehicles in the region was 46,732,785 units in 2021, a rise from 44,276,549 units in 2020. Similarly, the total sales in the region was 42,663,736 units in 2021, a rise from 40,322,544 in 2020.

The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.

Request Report Sample@ https://www.researchnester.com/sample-request-4402

Expand of Aerospace & Defense Industry to Drive the Market Growth

CFRPs are composite materials created by fusing a resin with carbon fiber reinforcement. They are suited for usage in a variety of industrial applications due to their considerable weight savings, enhanced tensile strength, fatigue resistance, impact resistance, and durability. CFRP materials are increasingly being used in place of metals in a variety of automobile applications, largely to minimize fuel consumption. They are utilized in the production of tennis racquets, aerospace and automotive components, protective helmets, wind turbine blades, molding compounds, building and construction plates, and imaging equipment structures. Because carbon is a potent absorbent, these materials can be utilized as chemical or water purifiers.

However, easy availability of other materials along with high costs incurred and long production cycles is expected to operate as key restraints to the growth of the global carbon fiber reinforced plastic market over the forecast period.

This report also provides the existing competitive scenario of some of the key players of the global carbon fiber reinforced plastic market which includes company profiling of SGL CARBON SE, Toray Industries, Inc., Röchling SE & Co. KG, Nikkiso Co., Ltd., Formosa Plastics Corporation, U.S.A., Teijin Limited, Hexcel Corporation, PHC Holdings Corporation, Nikkiso Co., Ltd., Nippon Graphite Fiber Co., Ltd., Solvay Group, and many more. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global carbon fiber reinforced plastic market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future. 

[roosevelthouseppi]

New Study Reveals Upsurge in Unionization and Strikes in Higher Education

Media Contacts: Ruth Milkman, 310-871-3055 William Herbert, 518-605-4402 NEW YORK, NY (August 31, 2023)— A new report released by the CUNY School of Labor and Urban Studies, State of the Unions 2023: A Profile of Organized Labor in New York City, New York State, and the United States, is a part of an annual publication series, documents recent trends in unionization patterns. As Figure 1a shows,…

[brisquad-unit-4402]

fuck it this but vtubers (in a non-parasocial way)

(yes vtubers outside of niji are allowed)

If anyone wants me to say my opinion on a character with this bingo

[didanawisgi]

Science’s COVID-19 reporting is supported by the Pulitzer Center.

On its face, it was a major finding: Antimalarial drugs touted by the White House as possible COVID-19 treatments looked to be not just ineffective, but downright deadly. A study published on 22 May in The Lancet used hospital records procured by a little-known data analytics company called Surgisphere to conclude that coronavirus patients taking chloroquine or hydroxychloroquine were more likely to show an irregular heart rhythm—a known side effect thought to be rare—and were more likely to die in the hospital.

Within days, some large randomized trials of the drugs—the type that might prove or disprove the retrospective study’s analysis—screeched to a halt. Solidarity, the World Health Organization’s (WHO’s) megatrial of potential COVID-19 treatments, paused recruitment into its hydroxychloroquine arm, for example. (Update: At a briefing on 3 June WHO announced it would resume that arm of the study.)

But just as quickly, the Lancet results have begun to unravel—and Surgisphere, which provided patient data for two other high-profile COVID-19 papers, has come under withering online scrutiny from researchers and amateur sleuths. They have pointed out many red flags in the Lancet paper, including the astonishing number of patients involved and details about their demographics and prescribed dosing that seem implausible. “It began to stretch and stretch and stretch credulity,” says Nicholas White, a malaria researcher at Mahidol University in Bangkok.

Today, The Lancet issued an Expression of Concern (EOC) saying “important scientific questions have been raised about data” in the paper and noting that “an independent audit of the provenance and validity of the data has been commissioned by the authors not affiliated with Surgisphere and is ongoing, with results expected very shortly.”

Hours earlier, The New England Journal of Medicine (NEJM) issued its own EOC about a second study using Surgisphere data, published on 1 May. The paper reported that taking certain blood pressure drugs including angiotensin-converting enzyme (ACE) inhibitors didn’t appear to increase the risk of death among COVID-19 patients, as some researchers had suggested. (Several studies analyzing other groups of COVID-19 patients support the NEJM results.) “Recently, substantive concerns have been raised about the quality of the information in that database,” an NEJMstatement noted. “We have asked the authors to provide evidence that the data are reliable.”

A third COVID-19 study using Surgisphere data has also drawn fire. In a preprint first posted in early April, Surgisphere founder and CEO Sapan Desai and co-authors conclude that ivermectin, an antiparasitic drug, dramatically reduced mortality in COVID-19 patients. In Latin America, where ivermectin is widely available, that study has led government officials to authorize the drug—although with precautions—creating a surge in demand in several countries.

Chicago-based Surgisphere has not publicly released the data underlying the studies, but today Desai told Science through a spokesperson that he was “arranging a nondisclosure agreement that will provide the authors of the NEJM paper with the data access requested by NEJM.”

Meanwhile, the questions swirling around the Lancet paper have left leaders of the halted chloroquine trials weighing whether to restart. “The problem is, we are left with all the damage that has been done,” says White, a co-investigator on a trial of hydroxychloroquine for COVID-19 prevention that was halted at the request of U.K. regulators last week. Headlines proclaiming deadly effects will make it hard to recruit patients to key studies, he says. “The whole world thinks now that these drugs are poisonous.”

A striking observation

Desai’s co-authors on the Lancet paper were cardiologist Mandeep Mehra of Harvard University’s Brigham and Women’s Hospital (BWH), cardiologist Frank Ruschitzka of the University Hospital Zürich, and cardiac surgeon Amit Patel, who listed affiliations with the University of Utah and HCA Research Institute in Nashville, Tennessee. Their study described an analysis of Surgisphere-provided electronic health record data from patients already treated for COVID-19 at 671 hospitals on six continents.

According to the paper, the analysis included nearly 15,000 patients prescribed chloroquine or hydroxychloroquine, alone or in combination with a class of antibiotics that has been suggested to boost its effects. A control group consisted of more than 81,000 patients who hadn’t gotten the experimental drugs. After controlling for potentially confounding factors such as age, race, pre-existing disease, and COVID-19 severity, the researchers found that the risk of dying in the hospital was 9.3% for the control group versus 23.8% for those getting hydroxychloroquine alongside an antibiotic—apparently the riskiest of the treatment combinations. The results echoed a preprint published last month, based on a much smaller group of patients in U.S. Veterans Health Administration medical centers, which suggested an increased risk of death for patients who were prescribed hydroxychloroquine alone (though not in combination with an antibiotic).

In 25 May media briefing, WHO Director-General Tedros Adhanom Ghebreyesus cited the Lancetresults in announcing a “temporary pause” in Solidarity’s hydroxychloroquine arm. Regulators in France and the United Kingdom also instructed investigators, including White’s team, to halt enrollment in trials of the malaria drug. And Sanofi, which manufactures the branded hydroxychloroquine drug Plaquenil, said it would temporarily stop recruiting patients to its two clinical trials of the drug.

The Lancet authors acknowledged their results needed confirmation from more rigorous randomized trials, but in an interview with TRT World, a Turkish channel for international news, Desai expressed confidence. “The real question is: With data like this, do we even need a randomized controlled trial?” he said.

Other researchers immediately took issue with the analysis. The study doesn’t properly control for the likelihood that patients getting the experimental drugs were sicker than the controls, says Matthew Semler, a critical care physician at Vanderbilt University. “If you have a physician sitting with two patients who have coronavirus, and the physician chooses to give one of them hydroxychloroquine, they’re doing it for a reason,” he says. The patient may be relying on high levels of supplemental oxygen, for example, or getting worse over time. But those kinds of details aren’t available about the patients in the Lancet study, he notes.

Other researchers were befuddled by the data themselves. Though 66% of the patients were reportedly treated in North America, the reported doses tended to be higher than the guidelines set by the U.S. Food and Drug Administration, White notes. The authors claim to have included 4402 patients in Africa, 561 of whom died, but it seems unlikely that African hospitals would have detailed electronic health records for so many patients, White says.

The study also reported more deaths in Australian hospitals than the country’s official COVID-19 death statistics, The Guardian reported. On 29 May, The Lancet issued a correction updating a supplemental table and saying that a hospital assigned to the study’s “Australasia” group should have been assigned to Asia. “There have been no changes to the findings of the paper,” the correction notice said.

Deepening skepticism

The brief response left some researchers frustrated. “This was very, very annoying, that The Lancetwere just going to let them write this absurd reply … without addressing any of the other concerns,” says James Watson, a statistician at Mahidol who on 28 May published an open letter to the journal and the study’s co-authors, signed by more than 200 clinicians and researchers, that calls for the release of Surgisphere’s hospital-level data, an independent validation of the results, and publication of the peer review comments that led to the Lancet publication.

Today, many of the same researchers published an open letter to NEJM and the authors of the ACE inhibitor study, citing similar problems in that journal’s paper. The letter notes a discrepancy between the small number of hospitals in each country that are reported to have shared patient data with Surgisphere and the high proportion of those countries’ confirmed COVID-19 cases reported in the study. It also notes inconsistencies in the reported increases in the risk of COVID-19 death with increasing age of participants.

Mehra and Patel declined to speak to reporters about the various papers, referring inquiries to BWH, which released a statement on Mehra’s behalf this evening saying “independent of Surgisphere, the remaining co-authors of the recent studies published in The Lancet and The New England Journal of Medicine have initiated independent reviews of the data used in both papers after learning of the concerns that have been raised about the reliability of the database.” (Ruschitzka, who is on the Lancet paper, has not yet responded to Science’s requests for comment.)

Oddities also appear in the ivermectin study, says Carlos Chaccour of the Institute for Global Health in Barcelona, who knows the drug well because he’s studying its potential role in mosquito control. There’s evidence that ivermectin has antiviral properties, and a study from an Australian team published in Antiviral Research on 3 April showed that it inhibits SARS-CoV-2 in a test tube. A 6 April preprint co-authored by Patel, Desai, and Mehra, along with David Grainger of the University of Utah, used Surgisphere data reportedly collected at 169 hospitals around the world between 1 January and 1 March. It included three patients in Africa who received ivermectin—despite the fact that only two COVID-19 cases had been reported in all of Africa by 1 March, Chaccour and two colleagues note in a recent blog post.

Chaccour says after he inquired about the discrepancy, the authors posted a second, longer version of the manuscript on 19 April, containing data collected between 1 January and 31 March. (The first version was removed but Chaccour has archived it on his institute’s website.) The new manuscript contained data on 704 COVID-19 patients treated with ivermectin and 704 controls in 169 hospitals on three continents. It reported that ivermectin reduced the need for mechanical ventilation by 65% and slashed the death rate by 83%.

But the revision had other problems, Chaccour and his colleagues wrote in their blog post. For example, the data shown in a figure were wildly different from those reported in the text. (Sciencealso attempted to reach Grainger, but received no reply to an email and call.)

The ivermectin study has had a significant impact in Latin America, where the drug is well known and often sold over the counter to treat scabies, Chaccour says. The Peruvian Health Ministry modified its COVID-19 treatment protocol to include ivermectin (as well as hydroxychloroquine) for mild and severe cases of COVID-19. Demand for the drug in Peru has surged, and in the San Martín de Porres district, police confiscated 20,000 bottles of veterinary ivermectin intended to be sold for human treatments. In Trinidad, Bolivia, the city government aimed to hand out more than 350,000 free doses of ivermectin after the country’s Ministry of Health authorized its use against COVID-19. Physicians in the Dominican Republic, Peru, and Chile, citing the test tube study and the Surgisphere preprint, say they performed informal trials of ivermectin with COVID-19 patients and saw good outcomes.

(In a guest editorial in The American Journal of Hygiene and Tropical Medicine, Chaccour and three colleagues cautioned against the risks of using ivermectin without solid evidence and urged rigorous clinical trials. Eighteen such studies are ongoing, according to the website ClinicalTrials.gov, including one led by Chaccour in Pamplona, Spain.)

Surgisphere’s sparse online presence—the website doesn’t list any of its partner hospitals by name or identify its scientific advisory board, for example—have prompted intense skepticism. Physician and entrepreneur James Todaro of the investment fund Blocktown Capital wondered in a blog postwhy Surgisphere’s enormous database doesn’t appear to have been used in peer-reviewed research studies until May. Another post, from data scientist Peter Ellis of the management consulting firm Nous Group, questioned how LinkedIn could list only five Surgisphere employees—all but Desai apparently lacking a scientific or medical background—if the company really provides software to hundreds of hospitals to coordinate the collection of sensitive data from electronic health records. (This morning, the number of employees on LinkedIn had dropped to three.) And Chaccour wonders how such a tiny company was able to reach data-sharing agreements with hundreds of hospitals around the world that use many different languages and data recording systems, while adhering to the rules of 46 different countries on research ethics and data protection.

Desai’s spokesperson responded to inquiries about the company by saying it has 11 employees and has been developing its database since 2008. Desai, through the spokesperson, also said of the company’s work with patient data: “We use a great deal of artificial intelligence and machine learning to automate this process as much as possible, which is the only way a task like this is even possible.”

What next?

The potential of hydroxychloroquine for treating COVID-19 has become a political flashpoint, and the questions around the Lancet paper have provided new fodder to the drug’s supporters. French microbiologist Didier Raoult, whose own widely criticized studies suggested a benefit from the drug, derided the new study in a video posted today, calling the authors “incompetent.” On social media, some speculated that the paper was part of a conspiracy against hydroxychloroquine.

For scientists running randomized trials of hydroxychloroquine, an urgent question has been how to respond to the paper and the many questions raised about it. Some studies were not halted at all. A hydroxychloroquine trial known as ORCHID, funded by the U.S. National Heart, Lung, and Blood Institute, opted to keep running after its data and safety monitoring board (DSMB) reviewed safety data from already enrolled participants, says Semler, a co-investigator on the study.

WHO’s paused Solidarity trial is awaiting a similar review from its DSMB, says Soumya Swaminathan, the organization’s chief scientist. The pause will allow time for a review of published studies and interim data from Solidarity itself, she says. WHO paused the trial to show investigators and potential study participants that the agency takes safety issues seriously, she says. “We want to reassure people that the WHO didn’t make any kind of value judgment on the use of hydroxychloroquine.”

But some say WHO had a knee-jerk reaction to a questionable study. “This is a drug that has been used for decades. It’s not like we know nothing about its safety,” says Miguel Hernán, a Harvard epidemiologist and co-investigator on an ongoing trial of hydroxychloroquine in Spain and Latin America for COVID-19 prevention in health care workers.

The controversy has been an unfortunate distraction, Hernán adds. “If you do something as inflammatory as this without a solid foundation, you are going to make a lot of people waste time trying to understand what is going on.”

Chaccour says both NEJM and The Lancet should have scrutinized the provenance of Surgisphere’s data more closely before publishing the studies. “Here we are in the middle of a pandemic with hundreds of thousands of deaths, and the two most prestigious medical journals have failed us,” he says.

With reporting by Rodrigo Pérez Ortega, Charlie Piller, and John Travis.

*Correction, 4 June, 10:50 a.m.: An earlier version of this story said one problem with the ivermectin study, according to Carlos Chaccour and his colleagues, was the strikingly low mortality rate, 21%, of COVID-19 patients who needed mechanical ventilation. It stated that a case series in the New York City area found that 88% of COVID-19 patients who needed ventilation died. However, that number was based on a paper in JAMA that was later corrected because the actual mortality for this group was much lower.  The sentence has been removed from the story.

[brisquad-unit-4402]

dude going on a date with vox to an animal shelter and you stay indoors with the kitties and one older cat resting on your lap as you look out the window and admire vox in his purest element running around and playing with some dogs. remind me to write something about this after a chug of coffee

[digitalconvo]

FLAMMABILITY TEST CHAMBER MARKET NEW ERA OF INDUSTRY & FORECAST 2019-2029

Global Flammability Test Chamber Market: Introduction

The flammability test chamber is made of stainless steel including large heat resistant window for the examination of the rate of combustion according to DIN 4402, DIN 53438, and other fire test. It is designed to test the flammability of equipment, appliance, component, and materials. The flammability machine has a wide range of test indicators for end-use such as combustion rate, flammability, flame spread, flame retardant and combustion intensity properties of products which can be tested. The flammability test chamber includes a high precision gas burner as well as an adjustable specimen support. Flammability test chamber also consist of exhaust fan, precise gas control system, flame height indicator and different specimen fixtures and holders.

The flammability test chamber is used for wide range of application such as the flammability testing of plastic materials used in electric devices, the tenacity of comparative burn rates of cloth such as napped and pile cloths, safety performance of the battery such as lithium ion, material used in the vehicle and many more applications

Get Brochure of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=6510

Global Flammability Test Chamber Market: Segmentation

Globally, the flammability test chamber market can be segmented on the basis of product type, and end-use industry

Based on the Product Type, the global flammability test chamber market can be segmented into,

Horizontal Flammability Test Chamber

Vertical Flammability Test Chamber

Based on the End-use Industry, the global flammability test chamber market can be segmented into,

Automotive Industry

Textile Industry

Electronics Industry

Building and Construction Industry

Aerospace Industry

Oil and Gas Industry

Pharmaceutical Industry

Global Flammability Test Chamber Market: Dynamics

Some of the standards such as American Society for Testing and Materials (ASTM) international standards organization developed and published technical standards for a wide range of products, materials, services and systems, creating lucrative opportunity for the demand of flammability test chamber. Moreover, the market is estimated drive by factors such as increasing government regulation towards the material used in the vehicle which need to have a degree of burn resistance and flammability in textile industry. For instance, in May 2019, major clothing brand American Apparel has recalled over 10,000 children’s “sleep sacks” because clothing items does not meet the U.S. federal flammability standard and the children’s sleep sacks easily catch fire, which can create burn hazard. Moreover, the fabrics must go through the flammability test because the synthetic fabrics does not burn and rather it melts, which can cause serious burns when they contact skin.

COVID-19:

However, COVID-19 affected countries worldwide, resulted into shutdown and negatively impact the global flammability test chamber market. As the market involved in automotive industry, textile industry, electronics industry, building and construction industry, aerospace industry, and oil & gas industry has slow down at rapid rate. Whereas, the COVID-19 stipulated to have some positive impact on the global flammability test chamber market as the market also worked in pharmaceutical industry.

To get Incredible Discounts on this Report, Click Here @https://www.tmrresearch.com/sample/sample?flag=D&rep_id=6510

Global Flammability Test Chamber Market: Regional Outlook

North America is estimated to hold a significant market share in flammability test chamber market. On the Country level, U.S. is expected to dominate the flammability test chamber market as they have implemented strictest mandatory flammability testing procedures, such as 16 CFR 1610, 16 CFR 1615 and 16 CFR 1616, requirements for clothing in the world in flammability test chamber market. Asia Pacific is estimated to contribute lucratively towards the overall flammability test chamber market as the region is witnessing increased automotive sales over the last decade. Europe is estimated to follow by Asia Pacific region as the increase consumer awareness about the importance of quality products is growing in this region. Latin America and Middle East & Africa are expected to witness less share in flammability test chamber market in the coming years as compared to other regions.

Global Flammability Test Chamber Market: Market Participants

Manufacturers of flammability test chamber are focusing on adding new automatic features in the machine such as automatic control system which is an intelligent instrument that displays the time, counting, burning time, residual flame time, residual burning time, etc. and there is no manuscript timing in the flammability test chamber, the test time of system automatically records in the automatic flammability test chamber machine.

Some of the key players involved in the flammability test chamber market include AMETEK ATLAS, Aegis Scientific, Karg Industrietechnik, Wewon Environmental Chambers Co., Ltd., Dongguan Lonroy Equipment Co., Ltd., DNG Technologies Private Limited, Intertek Group plc, VWR International, LLC, Bemco Inc., WTB Binder Labortechnik GmbH, among others.

The research report presents a comprehensive assessment of the flammability test chamber market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to flammability test chamber market segments such as product type, and application.

The report covers exhaustive analysis on:

Flammability Test Chamber Market Segments

Flammability Test Chamber Market Dynamics

Flammability Test Chamber Market Size

Flammability Test Chamber Volume Sales

Flammability Test Chamber Adoption Rate

Flammability Test Chamber Current Trends/Issues/Challenges

Flammability Test Chamber Competition & Companies involved

Flammability Test Chamber Value Chain

The market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various factors on flammability test chamber market segments and geographies.

Report Highlights:

Detailed overview of parent market

Changing market dynamics in the industry

In-depth market segmentation

Historical, current, and projected flammability test chamber market size in terms of value

Recent industry trends and developments

Competitive landscape

Strategies of key players and products offered

Potential and niche segments, geographical regions exhibiting promising growth

A neutral perspective on flammability test chamber market performance

Must-have information for flammability test chamber market players to sustain and enhance their market footprint

Request For TOC @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=6510

About TMR Research:

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:    

TMR Research, 3739 Balboa St # 1097, San Francisco, CA 94121 United States

Tel: +1-415-520-1050

[brisquad-unit-4402]

breaking the blog theme bc a ton of our fandom hinges on twt presence. any public tweets will be used to train elon’s ai project including images and media such as fanart. i wouldn’t be surprised if even normal tweets get recycled so the ai sounds more “human” (retches).

highly suggesting backing up your accounts on a different platform and then deleting your twt account before the end of september.

if any artists/writers/etc decide to jump ship on twt and you can’t find them, hopefully this explains why

elon musk should kill himself elon musk needs to kill himself elon musk would make society as a whole better if he killed himself now

[yespastpapercomposts-blog]

AQA GCSE Pastpapers

AQA GCSE Pastpapers, Exam Papers, Question Papers, Mark Schemes, Grade Thresholds & Syllabus

Pastpapers.co.in offers a wide range of free to use past exam papers, notes, pastpapers and other resources such as question practice papers as well as marking schemes of AQA GCSE tests to ensure you are always ready for that next exam of yours! Download AQA Pastpapers for GCSE  many such more, which are always up to date!

The Assessment and Qualifications Alliance (AQA) is an awarding body in England, Wales and Northern Ireland. It compiles specifications and holds examinations in various subjects at GCSE, AS and A Level and offers vocational qualifications. AQA is a registered charity and independent of the government. However, its qualifications and exam syllabi are regulated by the Government of the United Kingdom, which is the regulator for the public examinations system in England and Wales.

AQA is one of five awarding bodies which are recognised by schools across the country. AQA is also recognised by the regulators of the public exams systems for England, Wales and Northern Ireland to offer GCSE, AS and A Levels in the United Kingdom. AQA also offers the AQA Baccalaureate, a qualification also intended for students in Year 12 and 13 and which includes the study of three A-Levels, an extended project and extra-curricular enrichment activities. AQA is the largest examination board for GCSEs and GCE A Levels in England.

Art and Design (8201, 8202, 8203, 8204, 8205, 8206)

Art and Design (4200)

Bengali (8638)

Bengali (4635)

Biology (8461)

Biology (4401)

Business Subjects and Economics (4130)

Business (8132)

Citizenship Studies (8100)

Citizenship Studies (4105)

Chinese (Spoken Mandarin) (8673)

Chinese (Mandarin) (4670)

Chemistry (8462)

Chemistry (4402)

Classical Civilisation (4020)

Computer Science (4512)

ICT (4520)

Computer Science (8520)

Dance (8236)

Dance (4230)

Design and Technology Textiles Technology (4570)

Design and Technology Systems and Control Technology (4565)

Design and Technology Short Course (4575)

Design and Technology Resistant Materials (4560)

Design and Technology Product Design (4555)

Design and Technology Graphic Products (4550)

Design and Technology Food Technology (4545)

Design and Technology Electronic Products (4540)

Design and Technology (8552)

Drama (8261)

Drama (4240)

Engineering (8852)

Engineering (4580)

Electronics (4430)

Economics (8136)

Food Preparation and Nutrition (8585)

Expressive Arts (4260)

Environmental Science (4440)

English Literature (8702)

English Language (8700)

English Language (4705)

English (4700)

French (8658)

French (4655)

General Studies (4760)

Geography B (9035)

Geography A (9030)

Geography (8035)

Health and Social Care (4820)

German (4665)

German (8668)

Humanities (4070)

Human Health and Physiology (4415)

Home Economics Child Development (4580)

Home Economics Food and Nutrition (4585)

History (8145)

History B Full and Short Courses (9145)

Law (4160)

Italian (4630)

Italian (8633)

Leisure and Tourism (4840)

Linked Pair Methods in Mathematics (9365)

Linked Pair Applications of Mathematics (9370)

Media Studies (4810)

Mathematics Linear B (4365)

Mathematics (8300)

Music (4270)

Music (8271)

Modern Hebrew (4675)

Modern Hebrew (8678)

Physical Education (8582)

Physical Education (4890)

Performing Arts (4260)

Performing Arts (4880)

Panjabi (4680)

Panjabi (8683)

Psychology (8182)

Psychology (4180)

Polish (8688)

Polish (4685)

Physics (4403)

Physics (8463)

Religious Studies Short Course (8061)

Religious Studies B Full and Short Courses (4055)

Religious Studies B (8063)

Religious Studies A Full and Short Course (4050)

Religious Studies A (8062)

Spanish (8698)

Sociology (4190)

Spanish (4695)

Sociology (8192)

Statistics (8382)

Statistics (4310)

Urdu (4645)

Urdu (8648)

Search Keywords: AQA GCSE Pastpapers, AQA GCSE Examiner Reports, AQA GCSE question papers, AQA GCSE DipIFR pastpapers, AQA GCSE DipIFR question paper, AQA GCSE DipIFR examiner report. AQA GCSE pastpapers, AQA GCSE question papers, AQA GCSE notes, AQA GCSE examiner reports

[brisquad-unit-4402]

the dating sim i’ve been lucky enough to work on will be releasing soon this spring. please follow kronoprism’s official accounts for updates and goodies like character profiles and side content(?!), and of course, support everyone that made this game possible 💛

The demo for the upcoming Luxiem dating sim, Scrapbook Memories, is coming out THIS SPRING 🌸

You remembered that you got your letter from the school sometime after you took the exam.

After a while of decluttering your desk, you finally found it!

Divine Crown Academy is known to have one of the most difficult entrance exams in the nation. Suffice to say, you were quite surprised that you passed.

It looks like you’ll be able to check out the school this spring!

==================================

Follow kronoprism on Twitter and Instagram for further news and updates on the game ✨

kronoprism is non-profit and not affiliated with ANYCOLOR and NIJISANJI.

[footymanccave]

POLL: Who gets the better deal in a Pogba/Neymar swap - Man Utd or PSG?

POLL: Who gets the better deal in a Pogba/Neymar swap - Man Utd or PSG? #MUFC #PSG

Manchester United are toying with the idea of a swap deal of Pogba for Neymar.

Reports suggest that Paris Saint-Germain has approached Man Utd with a swap deal, Neymar for Pogba.

We have seen Ed Woodward bring big names to Manchester United since the departure of Sir Alex Ferguson, such as Falcao, Ibrahimovic, Paul Pogba, Di Maria, Schweinsteiger and most recently Alexis Sanchez.

With…

[predictoreports]

The global market size of D-MALIC ACID is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by the end of 2024 with a CAGR of XX% from 2019 to 2024. There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment. For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023. This report covers the following regions: * North America * South America * Asia & Pacific * Europe * MEA (Middle East and Africa) The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc. For end use/application segment, this report focuses on the status and outlook for key applications. End users sre also listed. * Application I * Application II * Application III For competitor segment, the report includes global key players of D-MALIC ACID as well as some small players. The information for each competitor includes:

[addictionrecoveryassistance]

Detox Centers In Loraine Illinois 62349

Contents

Methodist church church +1 217-938-4121

Care. treatment team member workers

School 304 west washington

304 west washington 217936-2512

Drug addiction rehab programs

Alcohol Rehab Centers Rehab Services » Alcohol Rehab Centers » IL » Alcohol Rehab Centers in Loraine 62349 Our website contains several top rated alcohol detox centers near Loraine that can help you with alcoholism treatment, religious drug and alcohol treatment centers…

Some drug and alcohol rehab programs near Loraine, only provide services for clients with certain conditions, such as men-only. Use our database of local addiction therapy centers to research topics such as cirrhosis of the liver and the specific addiction treatments to choose from.

Find local offers from businesses in Loraine, Illinois. Get customer reviews and write your own feedback about any company. 610 E Center St, Loraine, IL 62349, USA.

Loraine Village Office. 120 N Broad St Loraine, IL 62349 (217) 938-4182. … Harbor Village Detox & Treatment Center (4) … Drug Abuse & Addiction Centers. Website More Info. Harbor Village runs with the full of life approach and incorporates motivational support to focus on changing addictive behavior. The support groups…

Best of Loraine, Illinois – Find top Automotive, Financial Services, Community & Government Loraine is a village in Adams County, Illinois, United States. The population was 313 at the 2010 census.Wikipedia.org.  608 S Main St, Loraine, IL 62349. Gas stations, Convenience stores.

Rehab Services » Outpatient Rehab Centers » IL » Outpatient Rehab Centers in Loraine 62349 Outpatient Rehab Centers in Loraine, IL Both inpatient and outpatient addiction rehab centers near Loraine offer group counseling and individual therapy for their patients, so …

6 Homes For Sale in Loraine, IL. Browse photos, see new properties, get open house info, and research neighborhoods on Trulia. Loraine, IL Homes For Sale & Real Estate. ・6 homes available on Trulia. 307 N Main St Loraine IL 62349. SE Corner State Highway 336 & E #E Loraine IL 62349.

120 N Broad St Loraine, IL 62349 (217) 938-4182. Government Offices. Add to mybook Remove from mybook. … Harbor Village Detox & Treatment Center (26) Serving the Palmyra Area. (888) 266-8359. … The City of Quincy in Illinois offers a range of economic and community development services. The city government s planning department reviews and …

Call now 1-800-304-2219. The following article is will help you find treatments for drug and alcohol addiction in Quincy, Illinois.

Zillow has 6 homes for sale in 62349. View listing photos, review sales history, and use our detailed real estate filters to find the perfect place. 518 W Adams St LORAINE IL 62349. House for sale. By analyzing information on thousands of single family homes for sale in 62349, Illinois and across the…

Detox Centers In Glen Spey New York 12737 Glen Spey weather forecast from AccuWeather.com. Extended forecast in Glen Spey, NY 12737 for up to 25 days includes high temperature, RealFeel and chance of precipitation. In-Home and Group Home Daycare in Glen Spey, NY. Group home daycares are personable alternatives to large centers with hundreds of children. New York State Office of Children and

Substance Abuse Treatment Provider/DUI-Treatment Programs … Assessments / Evaluations · Treatment Classifications / Recommendations · Adult Treatment …

Luxury drug rehabs in Loraine, Illinois will provide the latest treatment with upscale amenities for anyone requiring the very best drug rehab, just as Loraine alcohol rehab centers will help those battling alcohol addiction to get sober.

Rehab Services » Alcohol Rehab Centers » IL » Alcohol Rehab Centers in Loraine 62349 Alcohol Rehab Centers in Loraine, IL Our website contains several top rated alcohol detox centers near Loraine that can help you with alcoholism treatment, religious drug and alcohol treatment centers, and other related topics.

Get help finding Alcohol and Drug Rehab Centers in Quincy, IL that are unique to your individual needs. Addiction treatment professionals are here to help 24/7.

Post Office in Loraine, Illinois on N Broad St. Operating hours, phone number, services information, and other locations near you. Loraine Post Office. 113 N Broad St, Loraine, IL 62349. Contact Numbers. Phone: 217-938-2915 TTY: 877-889-2457 Toll-Free: 1-800-Ask-USPS® (275-8777).

510 E Center St, Loraine, IL 62349. 877-579-9588. American General Life Insurance. United Methodist Church of Loraine. Clarksville Rd, Loraine, IL 62349. 217-938-4402. Loraine Elementary School.

Work closely in a team environment of 4 to 5 individuals in the training, collection, treatment, and movement of boars within a Gene Center.

Loraine, Illinois detailed profile. … home sales, real estate maps, and home value estimator for zip code 62349 …. Hospitals and medical centers near Loraine:.

Numerous start their dependency recovery procedure with a period of cleansing (detoxification), where the body rids itself of drugs, alcohol and other contaminants. Detox enables the body to bring back to a secure, toxin-free state. Some types of detoxification programs make use of …

Religious institutions located in Loraine, Illinois. You can always find the nearest religious institution in Loraine IL. Bean Family Cemetery Cemetery Loraine, Loraine, IL 62349. United methodist church church +1 217-938-4121 610 East Center Street, Loraine, IL 62349.

Illinois Loraine Loraine Inpatient Drug and Alcohol Rehab Facilities If you’re looking to help yourself or someone you love struggling with a drinking problem or addiction to drugs in Loraine, IL, Rehabs.com supplies a comprehensive online catalog of luxury private facilities, as well as a wealth of other choices.

Loraine Village Office is located in Loraine city of Illinois state. To communicate or ask something with the place, the Phone number is (217) 938-4182. : Broad Street. Zip Code. : 62349. City. : Loraine.

Detox Centers In Camilla Georgia 31730 Savannah Court of Camilla in Camilla: See 19 customer reviews, 7 candid photos and cost information for … FamilyAssets has estimated the cost of Savannah Court of Camilla assisted living Facility in Camilla, Georgia. … 161 East Broad Street, Camilla, GA, 31730 …. upson regional medical center distance: (14.69 miles). The drug detox centers near

Full information about Business services in Loraine, Illinois.Find the nearest location, opening hours and driving Get driving directions for every Business services location in Loraine. Write a review to rate 113 N Broad St, Loraine, Illinois 62349. You can: Write a review, view phone, address, hours…

Find A Detox Center Today! Detox Local not only provides an extensive directory of all available drug and alcohol detox centers that are located near you, Detox Local provides Detox Local provides its users with an extensive, country-wide database of all medical drug & alcohol detoxification facilities.

120 N Broad St Loraine, IL 62349 (217) 938-4182. Government Offices. Add to mybook Remove from mybook. … Harbor Village Detox & Treatment Center (26) Serving the Palmyra Area. (888) 266-8359. … The City of Quincy in Illinois offers a range of economic and community development services. The city government s planning department reviews and …

Lots of inpatient or residential recovery programs are offered with certified addiction healing centers. These immersive programs keep high criteria for addiction treatment care. treatment team member workers offer day-and-night supervision of program locals.

Rehab Services » Outpatient Rehab Centers » IL » Outpatient Rehab Centers in Loraine 62349 Outpatient Rehab Centers in Loraine, IL Some drug and alcohol rehab programs near Loraine, only provide services for clients with certain conditions, such as men-only.

Rehab Services » Outpatient Rehab Centers » IL » Outpatient Rehab Centers in Loraine 62349 Outpatient Rehab Centers in Loraine, IL Both inpatient and outpatient addiction rehab centers near Loraine offer group counseling and individual therapy for …

Looking for Drug Addiction Treatment in Abingdon IL for yourself or a loved one? Call (855)-848-5969 to speak to a friendly Illinois advisor today.

Search all the latest Loraine Il 62349 foreclosures available. Find the best home deals on the market in Loraine Il 62349. View homes for sale that are 30-50 Get information on foreclosure homes for rent, how to buy foreclosures in Loraine Il 62349 and much more. Save thousands at closing with home…

Ready to find a detox center in Quincy, ? Get off alcohol, opiates, and other drugs by browsing top detoxification programs.

Find private, inpatient rehabs in Quincy, Illinois including some of the Nation's top alcohol and drug rehab centers.

cent illinois conference box 162 114 n 2nd st greenville 62246 030030020 dr philip pogue … loraine 62349 217938-4400 dean herring mendon elementary school 304 west washington 217936-2512 … kenneth w young centers 1022 nerge rd 14016085y thomas martin st benedict high school …

Get the Loraine weather forecast. Access hourly, 10 day and 15 day forecasts along with up to the minute reports and videos for Loraine, IL 62349 from …

Find homes for sale and real estate in Loraine, IL at realtor.com®. Search and filter Loraine homes by price, beds, baths and property type. 307 N Main St Loraine IL 62349. Brokered by Bower. House for Sale.

Detox Centers In Franklin Indiana 46131 Centers.com. Home. Drugs. Detox. Treatment Centers. Franklin, Indiana Rehab Centers. Call800-721-8114and get help today! Tara Treatment Center Inc. 77 West Monroe Street Franklin, IN 46131. The Fix would like you to submit real Tara Treatment Center Inc reviews, if you have had an experience with their program, or know someone who has. If you’ve gone

loraine elementary school box 413 loraine 62349 217938-4400 dean herring mendon elementary school 304 west washington 217936-2512 01001005p c m ferra 01001005x sr norma somers st dominic school 4100 columbus rd 217224-0041 k-8 01001006p henry murray

Find intervention services, detox centers, and drug addiction rehab programs in Quincy, IL. Extensive listings include residential treatment and outpatient …

Find HOTELS in 62349 Loraine. Search by zip code for hotels near Loraine Illinois. Deals + discounts on lodging and motels in Adams county and area code 217. 4821 Oak St., Quincy, IL 62305 ~16.47 miles southwest of 62349. Affordable Highway property. Gym is available on property.

[brisquad-unit-4402]

working with chia has always been a ray of sunshine and super fun to collab with. i appreciate her and her work a ton! please show them some love and thank you for your support

Haha, seeing others doing an announcement, I was thinking I should also do the same.

Ahem, here we go—

—♡

Lovelies!— I may be on hiatus from writing here.. But, I am working on a project !

I am a member of this special project !

Check it out ! Give them a follow for further updates on the project ! Make sure you put the notifications on if you want to be kept updated <3

I hope you all look forward to this 🪄✨

© is right under the post i linked !